Home2696 • HKG
add
Shanghai Henlius Biotech Inc
Previous close
$65.65
Day range
$63.65 - $67.45
Year range
$23.00 - $92.00
Market cap
35.87B HKD
Avg Volume
1.14M
P/E ratio
38.33
Dividend yield
-
Primary exchange
HKG
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.92B | 29.17% |
Operating expense | 1.20B | 34.91% |
Net income | 218.46M | 0.63% |
Net profit margin | 11.36 | -22.09% |
Earnings per share | — | — |
EBITDA | 268.87M | -6.55% |
Effective tax rate | -4.53% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 772.21M | -5.10% |
Total assets | 12.36B | 16.64% |
Total liabilities | 8.40B | 10.77% |
Total equity | 3.96B | — |
Shares outstanding | 544.72M | — |
Price to book | 9.03 | — |
Return on assets | 3.94% | — |
Return on capital | 6.45% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 218.46M | 0.63% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2010
Website
Employees
3,537
